Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism

NCT: NCT06819865 · RECRUITING

NCT IDNCT06819865
StatusRECRUITING
Start Date2026-08-30
Completion2029-05-30
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.

Frequently Asked Questions

What is A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism?

A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism is a clinical trial registered under NCT06819865. Current status: RECRUITING.

What is the status of NCT06819865?

The current status of NCT06819865 (A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism) is: RECRUITING.

When did A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism start?

A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism started on 2026-08-30.

Related Devices

K211080EkoSonic Endovascular DeviceBoston Scientific K213422EkoSonic Endovascular Device, EKOS+ Endovascular DeviceBoston Scientific Corporation K182324EkoSonic Endovascular SystemBtg International, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑